For nearly a decade, omnichannel has been one of the defining themes of pharmaceutical customer engagement. Every major conference has devoted sessions to it, every large pharmaceutical organization has invested heavily in digital channels alongside traditional field engagement, and almost every commercial transformation roadmap has positioned omnichannel as a strategic priority. Yet despite these investments, many organizations continue to face the same challenge. Customers still experience disconnected interactions across channels, patients repeat the same information to different support teams, and healthcare providers receive communications that feel like isolated campaigns rather than part of one coordinated relationship. The industry has reached a point where adding more channels no longer creates a better customer experience. The conversation is now shifting toward something far more important, how those channels work together, respond to customer behavior, and create a seamless experience over time. That shift from omnichannel strategy to omnichannel orchestration is more than a change in terminology. It represents a fundamentally different way of thinking about customer engagement.
Why 2026 Represents a Turning Point
The timing is significant because three powerful trends are converging simultaneously, creating an environment where customer experience is no longer simply a competitive advantage but an operational necessity. Previous efforts focused largely on expanding digital capabilities, launching new communication channels, or building additional patient support programs. While these investments increased engagement opportunities, they did not necessarily improve the customer journey itself.
Three developments are now reshaping how pharmaceutical organizations approach customer experience:
- Digital engagement has become the primary channel rather than a complement to traditional field interactions.
- Generative and agentic AI are making personalization operationally achievable, removing many of the bottlenecks that previously limited scale.
- Organizations are moving beyond omnichannel strategies toward omnichannel orchestration, where every customer interaction influences what happens next.
Together, these shifts are changing not only how pharmaceutical companies communicate, but also how they organize customer engagement across the enterprise.
Digital Engagement Has Reached Scale. Experience Has Not.
According to DT Consulting’s benchmark research, digital channels now account for more than half of all healthcare provider interactions, marking the first time digital engagement has become the dominant mode of communication. At first glance, this appears to validate years of investment in digital transformation. However, the same research also found that while digital engagement increased, the quality of those interactions declined. That distinction highlights an important reality. Reaching customers digitally and serving them well through digital channels are fundamentally different capabilities.
Many organizations successfully expanded their digital presence, but relatively few redesigned the customer journey around those new channels. As a result, healthcare providers and patients often encounter fragmented experiences characterized by repetitive messaging, multiple disconnected portals, and communications that reflect internal organizational structures rather than customer needs.
AI Is Finally Solving the Operational Challenge
Personalization has long been recognized as one of the industry’s most important goals, yet implementing it at scale has proven difficult. Every variation of content required medical, legal, and regulatory review, making personalization expensive, time-consuming, and operationally complex. Consequently, many organizations settled for broad segmentation instead of delivering experiences tailored to individual customers.
Research from PwC’s Health Industries practice suggests this equation is beginning to change. AI-enabled modular content combined with automated medical, legal, and regulatory review allows organizations to assemble approved content dynamically while maintaining governance and compliance. Rather than producing hundreds of independent assets, companies can increasingly create flexible content components that adapt to customer needs without restarting the approval process each time.
The greatest contribution of AI to customer engagement may therefore not be its ability to generate content, but its ability to eliminate the operational friction that has prevented meaningful personalization from becoming practical at enterprise scale.
From Omnichannel Strategy to Omnichannel Orchestration
The industry’s evolving language reflects an important shift in thinking. An omnichannel strategy determines which communication channels an organization intends to use. Omnichannel orchestration focuses on a much more valuable question:
What should happen next based on what the customer just did?
Instead of executing a predetermined campaign calendar, orchestration continuously adapts based on customer behavior. Every interaction becomes a signal that shapes the next one.
For example:
- Did the physician open the email but ignore the follow-up?
- Did the patient abandon enrollment halfway through a support program?
- Has the caregiver consistently responded to text messages while ignoring email?
- Does the customer prefer digital interactions over speaking with a call center?
Rather than viewing these as reporting metrics collected after a campaign ends, orchestration treats them as real-time intelligence that determines future engagement. The experience becomes responsive instead of repetitive, creating interactions that feel connected rather than programmed.
Measuring What Actually Matters
As organizations adopt orchestration, traditional campaign metrics become less meaningful. Email open rates, click-through rates, and customer satisfaction surveys continue to provide useful information, but they no longer tell the complete story. Organizations making meaningful progress increasingly measure outcomes that matter both to patients and to the business.
These include:
- Medication adherence
- Time-to-therapy
- Reduction in patient support program dropout
- Faster patient access
- Successful enrollment completion
Equally important is the ability to act on customer preferences rather than simply collecting them.
Breaking Down Organizational Silos
Meaningful orchestration depends on a shared understanding of the customer across the enterprise and by creating this shared customer view enables every interaction to build naturally upon previous ones, reducing friction while creating a more consistent and coordinated experience.
Questions Every Pharma Leader Should Be Asking
As customer experience becomes a defining capability rather than a supporting function, leadership teams should challenge themselves with a few important questions:
- Are we measuring customer experience through campaign metrics or through patient outcomes?
- Do our communication channels genuinely work together, or are they simply operating in parallel?
- If we removed our internal organizational chart, would customers still experience one consistent relationship with our company?
- Are we using AI to generate more content, or to remove friction from the customer journey?
- Does every customer interaction make the next interaction smarter?
The organizations that improve customer experience most meaningfully in 2026 will be the ones that stop asking, “How do we communicate more?” and begin asking, “How do we make every interaction easier, more relevant, and more valuable for the person on the other end?”
Sources
- Deloitte. Unlocking the Future of Customer Engagement in Pharma
- DT Consulting. State of Customer Experience in the Global Pharmaceutical Industry
- PwC Health Industries. Customer Engagement Research
- McKinsey & Company. Life Sciences Omnichannel Research
If this area interests you further or are interested to be part of the 2026 Pharma CX Marketing Summit in October, please do get in touch with us.